FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dick Stockelberg

Research Profile

Geographic Areas

Disorders

Procedures

Chemicals & Drugs

Anatomy

Blood Platelets

Concepts & Ideas

Co-author Network

Publications

TOP 3
Mari Punab; Soodabeh Safai-Kutti; Dick Stockelberg; Mirja Varik; Lovisa Wennström; Hele Everaus; Erik Holmberg; Erik Hulegårdh; Edward Laane; Katrin Palk; Jack Kutti
Sequential population-based studies over 25 years on the incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1982-2006: a survey of patients aged ≥65 years.
Gunnar Juliusson; Holger Karbach; Karin Karlsson; Vladimir Lazarevic; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Anders Wahlin; Petar Antunovic; Mats Brune; Asa Derolf; Hans Hägglund; Helene Hallböök; Martin Höglund
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
S Lehmann; Lars Möllgård; A Ravn; Dick Stockelberg; Ulf Tidefelt; A Wahlin; Lovisa Wennström; A Rangert Derolf; P Antunovic; L Carlsson; S Deneberg; M Höglund; Gunnar Juliusson
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dick Stockelberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mari Punab; Soodabeh Safai-Kutti; Dick Stockelberg; Mirja Varik; Lovisa Wennström; Hele Everaus; Erik Holmberg; Erik Hulegårdh; Edward Laane; Katrin Palk; Jack Kutti
Sequential population-based studies over 25 years on the incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1982-2006: a survey of patients aged ≥65 years.
Medical oncology (Northwood, London, England) 2013;30(1):487.
2011: Gunnar Juliusson; Holger Karbach; Karin Karlsson; Vladimir Lazarevic; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Anders Wahlin; Petar Antunovic; Mats Brune; Asa Derolf; Hans Hägglund; Helene Hallböök; Martin Höglund
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
Cancer 2011;117(18):4238-46.
2011: S Lehmann; Lars Möllgård; A Ravn; Dick Stockelberg; Ulf Tidefelt; A Wahlin; Lovisa Wennström; A Rangert Derolf; P Antunovic; L Carlsson; S Deneberg; M Höglund; Gunnar Juliusson
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Leukemia 2011;25(7):1128-34.
2011: I Andersson; K Ahlberg; Dick Stockelberg; Lars-Olof Persson
Patients' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation.
European journal of cancer care 2011;20(3):368-79.
2011: Lovisa Wennström; Hele Everaus; Erik Holmberg; Ene Luik; Katrin Palk; Soodabeh Safai-Kutti; Dick Stockelberg; Krista Vaht; Mirja Varik; Iige Viigimaa; Jack Kutti
The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged 16-64 years.
Acta haematologica 2011;126(3):176-85.
2010: Katrin Palk; Ene Luik; Mirja Varik; Iige Viigimaa; Krista Vaht; Hele Everaus; Lovisa Wennström; Dick Stockelberg; Soodabeh Safai-Kutti; Erik Holmberg; Jack Kutti
The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged >or=65 years.
Cancer epidemiology 2010;34(1):24-8.
2009: S Skovbjerg; Christina Welinder-Olsson; N Kondori; E Kjellin; Forough L Nowrouzian; Agnes E Wold; Dick Stockelberg; P Larsson; Christine Wennerås
Optimization of the detection of microbes in blood from immunocompromised patients with haematological malignancies.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2009;15(7):680-3.
2009: Inger Andersson; Karin Ahlberg; Dick Stockelberg; Mats Brune; Lars-Olof Persson
Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning.
Cancer nursing 2009;32(4):325-34.
2009: Jan-Erik Johansson; Bengt Hasséus; P Johansson; C Eklöf; D Ohman; Dick Stockelberg
Gut protection by palifermin during autologous haematopoietic SCT.
Bone marrow transplantation 2009;43(10):807-11.
2009: Gunnar Juliusson; Petar Antunovic; Asa Derolf; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Ulf Tidefelt; Anders Wahlin; Mattias Höglund
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.
Blood 2009;113(18):4179-87.
2008: Mats Linderholm; Martin Höglund; Dick Stockelberg
[Specialist associations' mission: equal and good cancer care for all].
Läkartidningen 2008;105(5):306-7.
2008: I Andersson; M Hjermstad; Dick Stockelberg; Lars-Olof Persson
Health related quality of life in stem cell transplantation: clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19).
Acta oncologica (Stockholm, Sweden) 2008;47(2):275-85.
2007: Oliver A Cornely; Johan Maertens; Drew J Winston; John R Perfect; Andrew J Ullmann; THOMAS WALSH; David Helfgott; Jerzy Holowiecki; Dick Stockelberg; Yeow Tee Goh; Mario Petrini; Catherine J Hardalo; Ramachandran Suresh; David Angulo-Gonzalez
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
The New England journal of medicine 2007;356(4):348-59.
2007: Yuan Wei; Dick Stockelberg; Sara Hullberg; Anne Ricksten; Hans Wadenvik
Changes in expression of apoptosis-related genes are linked to the molecular response to imatinib treatment in chronic-phase chronic myeloid leukemia patients.
Acta haematologica 2007;117(2):83-90.
2006: Yuan Wei; Mats Hardling; Bob Olsson; Rahil Hezaveh; Anne Ricksten; Dick Stockelberg; Hans Wadenvik
Not all imatinib resistance in CML are BCR-ABL kinase domain mutations.
Annals of hematology 2006;85(12):841-7.
2006: Gunnar Juliusson; Rolf Billström; A Gruber; Eva Hellström-Lindberg; M Höglunds; Karin Karlsson; Dick Stockelberg; Ake Wahlin; Maria Aström; C Arnesson; U Brunell-Abrahamsson; J Carstensen; E Fredriksson; E Holmberg; K Nordenskjöld; F Wiklund
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.
Leukemia 2006;20(1):42-7.
2005: Helene Hallböök; H Hägglund; Dick Stockelberg; Per-Gunnar Nilsson; Karin Karlsson; M Björkholm; M Linderholm; Ake Wahlin; Olle Linder; Bengt Smedmyr
Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.
Bone marrow transplantation 2005;35(12):1141-8.
2004: Ene Luik; K Palk; Hele Everaus; M Varik; Tiiu Aareleid; Lovisa Wennström; E-L Juntikka; Soodabeh Safai-Kutti; Dick Stockelberg; Erik Holmberg; Jack Kutti
The incidence and survival of acute de novo leukaemias in Estonia and in a well-defined region of western Sweden during 1982-1996: a survey of patients aged > or =65 years.
Journal of internal medicine 2004;256(1):79-85.
2004: Lovisa Wennström; Eva-Lena Juntikka; Soodabeh Safai-Kutti; Dick Stockelberg; Erik Holmberg; Ene Luik; Hele Everaus; Katrin Palk; Mirja Varik; Tiiu Aareleid; Jack Kutti
The incidence and survival of acute de novo leukaemias in Estonia and in a well defined region of Western Sweden during 1982-1996: a survey of patients aged 16-64 years.
Leukemia & lymphoma 2004;45(5):915-21.
2004: Christina Löfgren; Christer Paul; Maria Aström; Robert Hast; M Hedenius; Richard Lerner; Jan Liliemark; I Nilsson; Stig Rödjer; Bengt Simonsson; Dick Stockelberg; Ulf Tidefelt; Magnus Björkholm
Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial.
British journal of haematology 2004;124(4):474-80.
2004: Mats Hardling; Yuan Wei; Lars Palmqvist; Birgitta Swolin; Dick Stockelberg; Bengt Gustavsson; Kerstin Ekeland-Sjöberg; Hans Wadenvik; Anne Ricksten
Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate.
Medical oncology (Northwood, London, England) 2004;21(4):349-58.
2003: Mattias Höglund; M Brune; B Sallerfors; Tomas Ahlgren; Rolf Billström; Michael Hedenus; Berit Markevärn; B Nilsson; Bengt Simonsson; Dick Stockelberg; Ake Wahlin
More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML.
Bone marrow transplantation 2003;32(12):1119-24.
2003: Dick Stockelberg; Mona Heurgren; Per Sjöli; Jaan Väärt; Ulf-Henrik Mellqvist; Bengt Kron
[CPP (Cost Per Patient) is functioning well in the everyday care. The myeloma care program in Vastra Gotaland--an illustrative example].
Läkartidningen 2003;100(42):3316-8.
2003: Susanne Bram; Birgitta Swolin; Stig Rödjer; Dick Stockelberg; Inger Ogärd; Hans Bäck
Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia.
Cancer genetics and cytogenetics 2003;142(2):107-14.
2002: P Wernstedt; M Brune; Per-Ola Andersson; B Gustavsson; Dick Stockelberg; Hans Wadenvik
Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.
Bone marrow transplantation 2002;30(12):971-3.
2002: Helene Hallböök; Bengt Simonsson; Tomas Ahlgren; Magnus Björkholm; Jan Carneskog; Gunnar Grimfors; Robert Hast; Karin Karlsson; Eva Kimby; Richard Lerner; Olle Linder; Mats Linderholm; Eva Löfvenberg; Claes Malm; Per-Gunnar Nilsson; Christer Paul; Leif Stenke; Dick Stockelberg; Ulf Tidefelt; Ingemar Turesson; Ann-Marie Uden-Blome; Lars Vilen; Ake Wahlin; Ingemar Winquist; Bengt Smedmyr
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.
British journal of haematology 2002;118(3):748-54.
2001: L Sjöblom; Hans-Göran Hårdemark; A Lindgren; Bo Norrving; M Fahlén; M Samuelsson; Lennart Stigendal; Dick Stockelberg; A Taghavi; L Wallrup; J Wallvik
Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study.
Stroke; a journal of cerebral circulation 2001;32(11):2567-74.
2001: Björn Andréasson; Göran Lindstedt; Dick Stockelberg; Hans Wadenvik; Jack Kutti
The relation between plasma thrombopoietin and erythropoietin concentrations in polycythaemia vera and essential thrombocythaemia.
Leukemia & lymphoma 2001;41(5-6):579-84.
2000: Per-Ola Andersson; Dick Stockelberg; Stefan Jacobsson; Hans Wadenvik
A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura.
Annals of hematology 2000;79(9):507-13.
1999: Dick Stockelberg; P Andersson; Einar Björnsson; S Björk; Hans Wadenvik
Plasma thrombopoietin levels in liver cirrhosis and kidney failure.
Journal of internal medicine 1999;246(5):471-5.
1999: A Taghavi; T Jonson; Dick Stockelberg
[Survey of complications following treatment with anticoagulants. A computerized search for hemorrhagic complications completes manual reporting].
Läkartidningen 1999;96(32-33):3421-4.
1999: Dick Stockelberg; Lennart Stigendal; H Eriksson
[Nurses working with anticoagulants--a new subspecialty? Time for a new and important kind of training].
Läkartidningen 1999;96(10):1205-7.
1999: Henry Eriksson; Ulf G Eriksson; Lars Frison; P O Hansson; Peter Held; Margareta Holmström; A Hägg; T Jonsson; Leif Lapidus; B Leijd; Dick Stockelberg; U Säfwenberg; A Taghavi; M Thorsén
Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMW thrombin inhibitor, in patients with acute DVT.
Thrombosis and haemostasis 1999;81(3):358-63.
1998: M Hou; Jan Carneskog; Ulf-Henrik Mellqvist; Dick Stockelberg; M Hedberg; Hans Wadenvik; Jack Kutti
Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis.
European journal of haematology 1998;61(2):119-22.
1998: Hans Wadenvik; Dick Stockelberg; M Hou
Platelet proteins as autoantibody targets in idiopathic thrombocytopenic purpura.
Acta paediatrica (Oslo, Norway : 1992). Supplement 1998;424():26-36.
1998: M Hou; Per-Ola Andersson; Dick Stockelberg; Ulf-Henrik Mellqvist; Börje Ridell; Hans Wadenvik
Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes.
British journal of haematology 1998;101(3):420-4.
1997: M Hou; E Horney; Dick Stockelberg; S Jacobsson; Jack Kutti; Hans Wadenvik
Multiple quinine-dependent antibodies in a patient with episodic thrombocytopenia, neutropenia, lymphocytopenia, and granulomatous hepatitis.
Blood 1997;90(12):4806-11.
1997: M Hou; Dick Stockelberg; Jack Kutti; Hans Wadenvik
Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies.
British journal of haematology 1997;98(1):64-7.
1996: Dick Stockelberg; M Hou; Lennart Rydberg; Jack Kutti; Hans Wadenvik
Evidence for an expression of blood group A antigen on platelet glycoproteins IV and V.
Transfusion medicine (Oxford, England) 1996;6(3):243-8.
1996: M Hou; Dick Stockelberg; Jack Kutti; Hans Wadenvik
Naturally occurring IgG autoantibodies to platelet cytoskeleton tropomyosin.
Thrombosis and haemostasis 1996;75(4):642-7.
1996: M Hou; Dick Stockelberg; Lennart Rydberg; Jack Kutti; Hans Wadenvik
Blood group A antigen expression in platelets is prominently associated with glycoprotein Ib and IIb. Evidence for an A1/A2 difference.
Transfusion medicine (Oxford, England) 1996;6(1):51-9.
1996: Dick Stockelberg; M Hou; S Jacobsson; Jack Kutti; Hans Wadenvik
Light chain-restricted autoantibodies in chronic idiopathic thrombocytopenic purpura, but no evidence for circulating clone B-lymphocytes.
Annals of hematology 1996;72(1):29-34.
1996: Dick Stockelberg; M Hou; S Jacobsson; Jack Kutti; Hans Wadenvik
Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA.
European journal of haematology 1996;56(1-2):72-7.
1995: M Hou; Dick Stockelberg; Jack Kutti; Hans Wadenvik
Glycoprotein IIb/IIIa autoantigenic repertoire in chronic idiopathic thrombocytopenic purpura.
British journal of haematology 1995;91(4):971-5.
1995: M Hou; Dick Stockelberg; Jack Kutti; Hans Wadenvik
Fab-mediated binding of glycoprotein Ib/IX and IIb/IIIa specific antibodies in chronic idiopathic thrombocytopenic purpura.
British journal of haematology 1995;91(4):944-50.
1995: M Hou; Dick Stockelberg; Jack Kutti; Hans Wadenvik
Antibodies against platelet GPIb/IX, GPIIb/IIIa, and other platelet antigens in chronic idiopathic thrombocytopenic purpura.
European journal of haematology 1995;55(5):307-14.
1995: H Carlsson; Dick Stockelberg; L Tengborn; I Braide; Jan Carneskog; Jack Kutti
Effects of Erwinia-asparaginase on the coagulation system.
European journal of haematology 1995;55(5):289-93.
1995: Dick Stockelberg; M Hou; S Jacobsson; Jack Kutti; Hans Wadenvik
Evidence for a light chain restriction of glycoprotein Ib/IX and IIb/IIIa reactive antibodies in chronic idiopathic thrombocytopenic purpura (ITP).
British journal of haematology 1995;90(1):175-9.
1995: B Forsberg; S Jacobsson; Dick Stockelberg; Jack Kutti; Lennart Rydberg; Hans Wadenvik
The platelet-specific alloantigen PlA1 (HPA-1a): a comparison of flow cytometric immunophenotyping and genotyping using polymerase chain reaction and restriction fragment length polymorphism in a Swedish blood donor population.
Transfusion 1995;35(3):241-6.